In conclusion, our findings not only elucidate the oncogenic role of NAT10 in HCC through ac4C‐mediated regulation of SMAD3 mRNA stability but also provide a promising avenue for therapeutic intervention with NAT10‐2023. The gene discussed is NAT10; the disease is hepatocellular carcinoma.